Last week, Strainprint, a leader in cannabis data and analytics, announced a partnership with Israeli research leaders, Lumir Lab and Gynica to conduct the world’s first international clinical study on the use of cannabis to treat endometriosis.
BofC’s Blaine Pearson caught up with Michelle Arbus, Strainprint’s VP of Research and Dr. Sari Prutchi Sagiv, Senior Scientist at Gynica to talk about the research.
Earlier this year, Greece became the latest EU country to make medical cannabis products available to patients. In February 2024,...
Curaleaf has finalised its $16m acquisition of Canadian cannabis producer Northern Green Canada (NGC), helping the company secure its foothold...
Earlier this year, Greece became the latest EU country to make medical cannabis products available to patients. In February 2024,...
Curaleaf has finalised its $16m acquisition of Canadian cannabis producer Northern Green Canada (NGC), helping the company secure its foothold...
US Rep. Earl Blumenauer, founding co-chair of the Congressional Cannabis Caucus, said he believes Saturday was the ‘last 4/20 celebration...
New York’s Governor Kathy Hochul has announced a new plan to ‘finally put an end to the chaos’ of unlicensed...
Cannabis criminalization ‘does little to curtail use’ according to a new study, which found only a 1.1% difference in regular...
Release is launching a vital initiative. We are launching the #ReleaseOurMeds campaign to protect the rights of patients to access...
Kentucky citizens could now have access to medical cannabis this year as the state’s Governor Andy Beshear announced plans to...
Germany’s cannabis decriminalisation takes effect On April 1, 2024, Germany’s long-fought CanG bill came into effect, seeing thousands of supporters...
The UK’s medical cannabis market is continuing to develop at pace, and a major reason behind this growth has been...
Medical cannabis patients in Washington could soon no longer have to pay the steep excise tax on their treatment. Washington’s...
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
